Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843-3120, United States.
Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180-31590, United States.
Biomacromolecules. 2020 Dec 14;21(12):5189-5199. doi: 10.1021/acs.biomac.0c01293. Epub 2020 Nov 2.
In a material-guided approach, instructive scaffolds that leverage potent chemistries may efficiently promote bone regeneration. A siloxane macromer has been previously shown to impart osteoinductivity and bioactivity when included in poly(ethylene glycol) diacrylate (PEG-DA) hydrogel scaffolds. Herein, phosphonated-siloxane macromers were evaluated for enhancing the osteogenic potential of siloxane-containing PEG-DA scaffolds. Two macromers were prepared with different phosphonate pendant group concentrations, poly(diethyl(2-(propylthio)ethyl)phosphonate methylsiloxane) diacrylate (PPMS-DA) and 25%-phosphonated analogue (PPMS-DA 25%). Macroporous, templated scaffolds were prepared by cross-linking these macromers with PEG-DA at varying mol % (15:85, 30:70, and 45:55 PPMS-DA to PEG-DA; 30:70 PPMS-DA 25% to PEG-DA). Other scaffolds were also prepared by combining PEG-DA with PDMS-MA (i.e., no phosphonate) or with vinyl phosphonate (i.e., no siloxane). Scaffold material properties were thoroughly assessed, including pore morphology, hydrophobicity, swelling, modulus, and bioactivity. Scaffolds were cultured with human bone marrow-derived mesenchymal stem cells (normal media) and calcium deposition and protein expression were assessed at 14 and 28 days.
在材料引导的方法中,利用强大化学物质的有指导作用的支架可以有效地促进骨再生。先前已经证明,硅氧烷大分子单体在包含聚乙二醇二丙烯酸酯 (PEG-DA) 水凝胶支架中时具有成骨诱导性和生物活性。在此,评估了膦酸酯硅氧烷大分子单体对增强含硅氧烷的 PEG-DA 支架的成骨潜力的作用。两种大分子单体通过不同的膦酸酯侧基浓度来制备,聚二乙基(2-(丙硫基)乙基)膦酸甲基硅氧烷二丙烯酸酯 (PPMS-DA) 和 25%-膦酸酯类似物 (PPMS-DA 25%)。通过将这些大分子单体与 PEG-DA 以不同的摩尔%交联来制备大孔、模板化支架 (15:85、30:70 和 45:55 的 PPMS-DA 与 PEG-DA;30:70 的 PPMS-DA 25%与 PEG-DA)。还通过将 PEG-DA 与 PDMS-MA(即没有膦酸酯)或乙烯基膦酸酯(即没有硅氧烷)组合来制备其他支架。彻底评估了支架材料的特性,包括孔形态、疏水性、溶胀、模量和生物活性。将支架在人骨髓间充质干细胞(正常培养基)中培养,并在 14 和 28 天评估钙沉积和蛋白质表达。